Premium
Thiolated Eudragit‐based Nanoparticles for Oral Insulin Delivery: Preparation, Characterization, and Evaluation Using Intestinal Epithelial Cells In Vitro
Author(s) -
Zhang Yan,
Du Xuli,
Zhang Yu,
Li Guofei,
Cai Cuifang,
Xu Jinghua,
Tang Xing
Publication year - 2014
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.201300515
Subject(s) - insulin , glutathione , permeation , chemistry , paracellular transport , nanocarriers , nanoparticle , intestinal epithelium , in vitro , caco 2 , biophysics , biochemistry , epithelium , drug delivery , materials science , endocrinology , nanotechnology , membrane , biology , organic chemistry , genetics , permeability (electromagnetism) , enzyme
This work deals with the synthesis of insulin loaded nanoparticles (NPs) composed of thiolated Eudragit L100 (Eul‐cys) and reduced glutathione (GSH) as potential nanocarriers for oral delivery of insulin. Perfectly spherical NPs with an average particle size of nearly 200–300 nm are prepared. The insulin release from Eul‐cys/GSH and Eul‐cys NPs in PBS (pH 7.4) shows that GSH can slightly decrease the release rate of insulin. Eul‐cys in combination with GSH or sodium caprate (SC) is evaluated for its permeation enhancing effect of FITC‐insulin using the Caco‐2 monolayer and Caco‐2/HT29‐MTX co‐cultured cells models. SC results in greater permeation enhancement compared to GSH. However, GSH proves to be less toxic. Paracellular transport of insulin represents the main mechanism by which the NPs facilitate insulin permeation through the intestinal epithelium, whereas a number of NPs are also taken up by the cells and release insulin within the cells.